Vanguard Asset Management’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$470K Buy
21,474
+5,995
+39% +$165K ﹤0.01% 2211
2026
Q2
$494K Buy
15,479
+6,488
+72% +$215K ﹤0.01% 2191
2026
Q1
$344K Buy
+8,991
New +$291K ﹤0.01% 2253

Other funds holding TYRA

Vanguard Asset Management's TYRA Position: Q3 2026 in Review

Vanguard Asset Management increased its Tyra Biosciences (TYRA) stake by 39% in Q3 2026, buying an estimated $165K and bringing the position to 21,474 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #2211.

Vanguard Asset Management first reported a position in TYRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $494K in Q2 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Vanguard Asset Management held 21,474 shares of Tyra Biosciences worth $470K as of Q3 2026.
  • Vanguard Asset Management bought 5,995 Tyra Biosciences shares in Q3 2026, an estimated $165K.
  • Tyra Biosciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2211 holding.
  • Vanguard Asset Management first reported a position in Tyra Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Tyra Biosciences position peaked at $494K in Q2 2026.
  • 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.